We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH) (ERICH)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01202864
Recruitment Status : Completed
First Posted : September 16, 2010
Last Update Posted : September 1, 2017
Information provided by (Responsible Party):

Study Description
Brief Summary:
The purpose of this study is to find risk factors for hemorrhagic stroke, specifically intracerebral hemorrhage (ICH), among Caucasians, African Americans, and Hispanics.

Condition or disease
Intracerebral Hemorrhage

Study Design

Study Type : Observational
Actual Enrollment : 6000 participants
Observational Model: Case-Control
Time Perspective: Other
Official Title: Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Actual Study Start Date : August 1, 2010
Primary Completion Date : July 31, 2017
Study Completion Date : August 1, 2017

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Bleeding
U.S. FDA Resources

Groups and Cohorts

3000 Cases
3000 Controls

Outcome Measures

Biospecimen Retention:   Samples With DNA
whole blood

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Our purpose is to enroll 1000 cases of ICH among whites, 1000 cases of ICH among blacks, and 1000 cases of ICH among Hispanics.

3000 controls matched to cases by race/ethnicity, age (+/- 5 years), gender, and geographic location.


Inclusion Criteria:

All cases must meet the following eligibility criteria:

  1. Age 18 years or greater, fulfillment of the criteria for intracerebral hemorrhage
  2. Resident for at least 6 months within 50 miles of the recruiting center
  3. No evidence of trauma, vascular malformation or aneurysm, or brain tumor as a cause of the hemorrhage
  4. Ability of the patient or legal representative to provide informed consent

Exclusion Criteria:

Exclusion Criteria:

  1. Malignancies leading to coagulopathy
  2. Hemorrhagic transformation of ischemic infarct
  3. Hemorrhage secondary to dural venous sinus thrombosis
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01202864

United States, Arizona
University of Arizona
Tucson, Arizona, United States, 85724
United States, California
University of Southern California
Los Angeles, California, United States, 90033
United States, District of Columbia
Georgetown University
Washington, D.C., District of Columbia, United States, 20007
United States, Florida
University of Miami - Biorepository
Miami, Florida, United States, 33136
University of Miami
Miami, Florida, United States, 33136
United States, Georgia
Emory University
Atlanta, Georgia, United States, 30303
United States, Illinois
University of Illinois
Chicago, Illinois, United States, 60612
United States, Maryland
University of Maryland
Baltimore, Maryland, United States, 21201
United States, Massachusetts
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114
United States, New Mexico
University of New Mexico
Albuquerque, New Mexico, United States, 87131
United States, New York
Columbia University
New York, New York, United States, 10032
United States, North Carolina
Wake Forest University
Winston-Salem, North Carolina, United States, 27157
United States, Texas
University of Texas Southwestern Medical Center at Dallas
Dallas, Texas, United States, 75390
University of Texas Medical School at Houston
Houston, Texas, United States, 77030
University of Texas Health Science Center at San Antonio
San Antonio, Texas, United States, 78229
Sponsors and Collaborators
University of Cincinnati
Massachusetts General Hospital
Columbia University
University of Maryland
Georgetown University
Wake Forest University
Emory University
University of Miami
University of Illinois at Chicago
University of Texas, Southwestern Medical Center at Dallas
The University of Texas Health Science Center, Houston
The University of Texas Health Science Center at San Antonio
University of New Mexico
University of Arizona
University of Southern California
St. Luke's-Roosevelt Hospital Center
University of California, San Francisco
Duke University
University of Virginia
National Institute of Neurological Disorders and Stroke (NINDS)
Principal Investigator: Daniel Woo, MD, MS University of Cincinnati
Principal Investigator: Matthew Flaherty, MD University of Cincinnati
More Information


Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Daniel Woo, Professor, University of Cincinnati
ClinicalTrials.gov Identifier: NCT01202864     History of Changes
Other Study ID Numbers: 1008059
R01NS069763-01 ( Other Grant/Funding Number: NINDS )
First Posted: September 16, 2010    Key Record Dates
Last Update Posted: September 1, 2017
Last Verified: August 2017

Keywords provided by Daniel Woo, University of Cincinnati:
Intracerebral Hemorrhage
Cerebrovascular accident

Additional relevant MeSH terms:
Cerebral Hemorrhage
Pathologic Processes
Intracranial Hemorrhages
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Vascular Diseases
Cardiovascular Diseases